Seres Therapeutics Profit Margin 2013-2021 | MCRB
Current and historical gross margin, operating margin and net profit margin for Seres Therapeutics (MCRB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Seres Therapeutics net profit margin as of June 30, 2021 is -441.65%.
|Seres Therapeutics Annual Profit Margins
|Seres Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Seres Therapeutics, Inc. offers microbiome therapeutics platform. It is focused on developing Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. Seres Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.